5-Amino-1MQ: A Research Deep-Dive into NNMT Inhibition and Metabolic Studies
Share
For laboratory and research use only. The information below is provided strictly for educational and scientific reference. This compound is not intended for human consumption, diagnosis, or treatment.
Among the metabolic research compounds studied in laboratory settings, 5-Amino-1MQ occupies an unusual position. It is not a peptide in the strict chemical sense — it is a small molecule — yet it appears consistently alongside research peptides in metabolic literature because of the pathway it acts on. For researchers in the Philippines building out a metabolic study panel, understanding what distinguishes it from peptide-based compounds is the starting point.
What 5-Amino-1MQ Is
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule compound described in the scientific literature as an inhibitor of nicotinamide N-methyltransferase, commonly abbreviated NNMT. Unlike the chains of amino acids that make up compounds such as MOTS-C research peptide, 5-Amino-1MQ is a quinolinium derivative with a low molecular weight. That structural difference matters in the laboratory: it changes solubility behaviour, handling requirements, and how the compound is prepared for in-vitro work.
Researchers sourcing it typically obtain it as a lyophilised powder in a sealed vial, the same presentation used across most 5-Amino-1MQ research compound laboratory inventory.
The NNMT Pathway in Research Literature
NNMT is an enzyme that methylates nicotinamide, a form of vitamin B3. Because nicotinamide sits upstream of NAD+ biosynthesis, published studies have examined whether modulating NNMT activity shifts the balance of the cellular NAD+ pool. This is the mechanistic reason NNMT-focused compounds are studied in parallel with NAD+ research models.
Areas that appear in the published research literature include:
- Adipocyte energy expenditure in cell-culture and rodent models
- Cellular NAD+ and S-adenosylmethionine (SAM) balance
- Methylation-pathway signalling in metabolic tissue
- Enzyme-inhibition kinetics and selectivity profiling
These are observations from controlled scientific studies. They describe what has been measured in laboratory models, not outcomes in any other context.
Where It Sits Alongside Other Metabolic Research Compounds
Laboratories assembling a metabolic research panel often hold several compounds that act on distinct mechanisms, which allows comparative study design. 5-Amino-1MQ is studied as an enzyme inhibitor. By contrast, SLU-PP-322 research compound is characterised in the literature as an ERR agonist, and L-Carnitine research solution is investigated in the context of fatty-acid transport. Grouping compounds by mechanism rather than by outcome is standard practice in study design and helps keep comparisons meaningful.
Laboratory Handling and Solubility Notes
Because 5-Amino-1MQ is a small molecule rather than a peptide, its solvent behaviour differs from typical peptide reconstitution workflows. Laboratory documentation and certificates of analysis should always be consulted for the specific lot in hand, since solubility can vary with salt form and purity.
General good-practice points that apply across research compound handling include:
- Confirm the stated mass on the vial label against the accompanying documentation before any calculation
- Use a sterile, appropriately selected diluent — many workflows draw on bacteriostatic water for laboratory preparation for peptide work, though small molecules may require a different solvent system
- Record the exact volume added so concentration can be recalculated and audited later
- Avoid repeated freeze-thaw cycles, which are a common source of degradation in reconstituted material
- Label every prepared aliquot with compound, concentration, solvent, and date
Storage and Stability
Lyophilised research compounds are generally most stable when kept sealed, cool, dry, and shielded from light. Once in solution, stability windows shorten considerably, which is why many laboratories prepare small working aliquots rather than reconstituting an entire vial at once. Ambient conditions in the Philippines — consistently warm and humid — make refrigerated storage and prompt handling on receipt particularly relevant for laboratories here.
Evaluating Research-Grade Supply
Reproducibility depends on knowing what is in the vial. Researchers evaluating a supplier typically look for clearly stated compound identity and mass, consistent vial labelling, analytical documentation, and packaging that protects material in transit. Comparing documentation across compounds before purchasing is a practical way to assess consistency — you can browse the full range of research peptides and review how each listing is presented.
Summary
5-Amino-1MQ is studied in the scientific literature as an NNMT inhibitor, placing it in the methylation and NAD+ research space rather than in the receptor-agonist category that most metabolic research peptides occupy. Its small-molecule structure gives it different handling characteristics from peptide compounds, and laboratories working with it should treat solvent selection, concentration documentation, and storage discipline as part of the experimental record rather than as afterthoughts.
Products are sold strictly for laboratory research and are not for human or animal consumption.